Cognate interactions between mast cells and helper T lymphocytes

Self/Nonself - Immune Recognition and Signaling

Volumn 1, Issue 2, 2010, Pages 114-122

  Valitutti, Salvatore ^a   Espinosa, Eric ^b  

^a France   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Antigen presentation; Helper T cell; Immunological synapse; Mast cell; T cell antigen receptor

Indexed keywords

GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL COMMUNICATION; CELL INTERACTION; CYTOKINE PRODUCTION; CYTOLOGY; EFFECTOR CELL; HELPER CELL; HUMAN; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE PROLIFERATION; MAST CELL; REVIEW; TH1 CELL; TH2 CELL;

EID: 77954902327     PISSN: 19382030     EISSN: 19382049     Source Type: Journal    
DOI: 10.4161/self.1.2.11795     Document Type: Review

References (85)

1. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77:1033-79.
2. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4:787-99.
3. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7:93-104.
4. Moon TC, St. Laurent CD, Morris KE, Marcet C, Yoshimura T, Sekar Y, et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 2010; 3:111-28.
5. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008; 454:445-54.
6. Wershil BK, Mekori YA, Murakami T, Galli SJ. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987; 139:2605-14.
7. Heib V, Becker M, Taube C, Stassen M. Advances in the understanding of mast cell function. Br J Haematol 2008; 142:683-94.
8. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-86.
9. Stelekati E, Orinska Z, Bulfone-Paus S. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 2007; 212:505-19.
10. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003; 4:1199-205.
11. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNFalpha. Nature 1996; 381:77-80.
12. Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNFalpha)/cachectin by mouse mast cells stimulated via the FcepsilonRI. A mechanism for the sustained action of mast cell-derived TNFalpha during IgE-dependent biological responses. J Exp Med 1991; 174:103-7.
13. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNFalpha/ cachectin. Nature 1990; 346:274-6.
14. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNFalpha. Circulation 1996; 94:2787-92.
15. Olszewski MB, Groot AJ, Dastych J, Knol EF. TNF trafficking to human mast cell granules: mature chaindependent endocytosis. J Immunol 2007; 178:5701-9.
16. Kunder CA, St. John AL, Li G, Leong KW, Berwin B, Staats HF, et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009; 206:2455-67.
17. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006; 107:610-8.
18. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 2004; 114:21-7.
19. Frossi B, Rivera J, Hirsch E, Pucillo C. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 2007; 178:2549-55.
20. Henz BM, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001; 10:1-10.
21. Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997; 159:2904-10.
22. Tedla N, Wang HW, McNeil HP, Di Girolamo N, Hampartzoumian T, Wakefield D, et al. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1alpha and MIP-1beta. J Immunol 1998; 161:5663-72.
23. Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeil PH. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998; 102:1617-26.
24. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005;102:6467-72.
25. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176:2238-48.
26. Kashiwakura J, Yokoi H, Saito H, Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 2004; 173:5247-57.
27. Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 2006; 18:751-60.
28. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008; 26:705-39.
29. Mazzoni A, Siraganian RP, Leifer CA, Segal DM. Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol 2006; 177:3577-81.
30. Gregory GD, Raju SS, Winandy S, Brown MA. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 2006; 116:1327-36.
31. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413:420-5.
32. Razin E, Ihle JN, Seldin D, Mencia-Huerta JM, Katz HR, LeBlanc PA, et al. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 1984; 132:1479-86.
33. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392:90-3.
34. Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5 and IL-6 on the survival of cultured human mast cells. Blood 1995; 86:3705-14.
35. Inamura N, Mekori YA, Bhattacharyya SP, Bianchine PJ, Metcalfe DD. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J Immunol 1998; 160:4026-33.
36. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29:771-81.
37. Bhattacharyya SP, Drucker I, Reshef T, Kirshenbaum AS, Metcalfe DD, Mekori YA. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 1998; 63:337-41.
38. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNFalpha. J Immunol 2001; 167:4008-16.
39. Smith TJ, Weis JH. Mucosal T cells and mast cells share common adhesion receptors. Immunol Today 1996; 17:60-3.
40. Mekori YA, Metcalfe DD. Mast cell-T cell interactions. J Allergy Clin Immunol 1999; 104:517-23.
41. Friedman MM, Kaliner M. In situ degranulation of human nasal mucosal mast cells: ultrastructural features and cell-cell associations. J Allergy Clin Immunol 1985; 76:70-82.
42. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6:135-42.
43. Daeron M, Voisin GA. Mast cell membrane antigens and Fc receptors in anaphylaxis I. Products of the major histocompatibility complex involved in alloantibody-induced mast cell activation. Immunology 1979; 38:447-58.
44. Kambayashi T, Baranski JD, Baker RG, Zou T, Allenspach EJ, Shoag JE, et al. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 2008; 111:1489-96.
45. Malbec O, Roget K, Schiffer C, Iannascoli B, Dumas AR, Arock M, et al. Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells. J Immunol 2007; 178:6465-75.
46. sai M, T akeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, et al. Induction of mast cell proliferation, maturation and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 1991; 88:6382-6.
47. Enerback L. Mast cells in rat gastrointestinal mucosa 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand 1966; 66:303-12.
48. Kambayashi T, Allenspach EJ, Chang JT, Zou T, Shoag JE, Reiner SL, et al. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol 2009; 182:4686-95.
49. Gaudenzio N, Espagnolle N, Mars LT, Liblau R, Valitutti S, Espinosa E. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood 2009; 114:4979-88.
50. Wong GH, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW. Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci USA 1982; 79:6989-93.
51. Koch N, Wong GH, Schrader JW. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma. J Immunol 1984; 132:1361-9.
52. Frandji P, Oskeritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 1993; 151:6318-28.
53. Warbrick EV, Taylor AM, Botchkarev VA, Coleman JW. Rat connective tissue-type mast cells express MHC class II: upregulation by IFNgamma. Cell Immunol 1995; 163:222-8.
54. Banovac K, Neylan D, Leone J, Ghandur-Mnaymneh L, Rabinovitch A. Are the mast cells antigen presenting cells? Immunol Invest 1989; 18:901-6.
55. Poncet P, Arock M, David B. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation. J Leukoc Biol 1999; 66:105-12.
56. Grabbe J, Karau L, Welker P, Ziegler A, Henz BM. Induction of MHC class II antigen expression on human HMC-1 mast cells. J Dermatol Sci 1997; 16:67-73.
57. Love KS, Lakshmanan RR, Butterfield JH, Fox CC. IFNgamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC1. Cell Immunol 1996; 170:85-90.
58. Littman BH, Dastvan FF, Carlson PL, Sanders KM. Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFNgamma. J Immunol 1989; 142:520-5.
59. Pai RK, Askew D, Boom WH, Harding CV. Regulation of class II MHC expression in APCs: roles of types I, III and IV class II transactivator. J Immunol 2002; 169:1326-33.
60. Lombard-Platet S, Meyer V, Ceredig R. Both IFNgamma and IL-4 induce MHC class II expression at the surface of mouse pro-B cells. Dev Immunol 1997; 5:115-20.
61. Stuart PM, Zlotnik A, Woodward JG. Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). J Immunol 1988; 140:1542-7.
62. Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mecheri S. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 1996; 26:251728.
63. Reshef A, MacGlashan DW. Immunogold probe for the light-microscopic phenotyping of human mast cells and basophils. J Immunol Methods 1987; 99:213-9.
64. Suzumura Y, Ohasi M. Immunoelectron microscopic localization of HLA-DR antigen on mast cells and vessels in normal and tuberculin-reactive skin. Am J Dermatopathol 1991; 13:568-74.
65. Banovac K, Ghandur-Mnaymneh L, Leone J, Neylan D, Rabinovitch A. Intrathyroidal mast cells express major histocompatibility complex class-II antigens. Int Arch Allergy Appl Immunol 1989; 90:43-6.
66. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 2004; 5:685-92.
67. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998; 93:1135-45.
68. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 1997; 8:2631-45.
69. Vincent-Schneider H, Thery C, Mazzeo D, Tenza D, Raposo G, Bonnerot C. Secretory granules of mast cells accumulate mature and immature MHC class II molecules. J Cell Sci 2001; 114:323-34.
70. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, et al. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999; 10:197-206.
71. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4:357-66.
72. Nishimoto H, Lee SW, Hong H, Potter KG, Maeda-Yamamoto M, Kinoshita T, et al. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 2005; 106:4241-8.
73. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol 1994; 158:253-64.
74. Frandji P, Tkaczyk C, Oskeritzian C, Lapeyre J, Peronet R, David B, et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol 1995; 163:37-46.21
75. Tkaczyk C, Viguier M, Boutin Y, Frandji P, David B, Hebert J, et al. Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation. Immunology 1998; 94:318-24.
76. Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y, et al. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol 2009; 10:706-12.
77. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol 2009; 10:697-705.
78. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10:713-20.
79. Trautmann A, Valitutti S. The diversity of immunological synapses. Curr Opin Immunol 2003; 15:249-54.
80. Valitutti S, Dupre L. Plasticity of immunological synapses. Curr Top Microbiol Immunol 340:209-28.
81. Tharp MD, Seelig LL Jr, Tigelaar RE, Bergstresser PR. Conjugated avidin binds to mast cell granules. J Histochem Cytochem 1985; 33:27-32.
82. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 1984; 83:214-8.
83. Depoil D, Zaru R, Guiraud M, Chauveau A, Harriague J, Bismuth G, et al. Immunological synapses are versatile structures enabling selective T cell polarization. Immunity 2005; 22:185-94.
84. Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med 1995; 181:577-84.
85. Stelekati E, Bahri R, D'Orlando O, Orinska Z, Mittrucker HW, Langenhaun R, et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009; 31:665-76.